|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/451 | (2006.01) |
| A61K 9/1617 | (2013.01) | ||
| C07D 211/20 | (2006.01) | ||
| A61K 9/1652 | (2013.01) | ||
| C07D 211/24 | (2006.01) | ||
| A61K 9/2009 | (2013.01) | ||
| A61K 9/16 | (2006.01) | ||
| A61K 9/2054 | (2013.01) | ||
| A61P 25/08 | (2006.01) | ||
| A61K 9/2059 | (2013.01) | ||
| A61K 9/2068 | (2013.01) | ||
| A61P 25/16 | (2006.01) | ||
| A61P 25/28 | (2006.01) | ||
| A61K 31/451 | (2013.01) | ||
| A61P 25/00 | (2018.01) | ||
| A61P 25/14 | (2018.01) | ||
| A61P 25/16 | (2018.01) | ||
| A61P 25/18 | (2018.01) | ||
| A61P 25/20 | (2018.01) | ||
| A61P 25/22 | (2018.01) | ||
| A61P 25/24 | (2018.01) | ||
| A61P 25/28 | (2018.01) | ||
| A61P 25/30 | (2018.01) | ||
| A61P 25/32 | (2018.01) | ||
| A61P 25/36 | (2018.01) |
| (11) | Number of the document | 3096759 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15740303.1 |
| Date of filing the European patent application | 2015-01-21 | |
| (97) | Date of publication of the European application | 2016-11-30 |
| (45) | Date of publication and mention of the grant of the patent | 2022-04-06 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2015/012248 |
| Date | 2015-01-21 |
| (87) | Number | WO 2015/112601 |
| Date | 2015-07-30 |
| (30) | Number | Date | Country code |
| 201461930358 P | 2014-01-22 | US | |
| 201462050626 P | 2014-09-15 | US |
| (72) |
LICHT, Daniella , IL
LOVINGER, Ioana , IL
GUILATT, Laura Yehudit , IL
BASSAN, Merav , IL
|
| (73) |
Prilenia Neurotherapeutics Ltd. ,
10 HaMenofim Street, Herzliya 4672561,
IL
|
| (54) | MODIFIED RELEASE FORMULATIONS OF PRIDOPIDINE |
| MODIFIED RELEASE FORMULATIONS OF PRIDOPIDINE |